Medicenna Therapeutics Corp., 2026-07-06
An SEC Form D private-offering notice from Toronto, ON, Canada, a $2,343,400 filer-stated offering target in Biotech. Filed 2026-07-06. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage immuno-oncology biotech developing engineered interleukin based cytokine therapies (Superkine, BiSKIT platforms) for cancer, publicly traded on NASDAQ/TSX as MDNA.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Amlogenyx Inc., 2026-07-09, $20M, Novato, CA
- MicroPure Genomics, Inc., 2026-07-08, $2M, San Diego, CA
- Lifeward Ltd., 2026-07-08, Hudson, MA
- HOPE-Neuron Therapeutx, Inc., 2026-07-02, $150K, Phoenix, AZ
- NurExone Biologic Inc., 2026-07-02, $442K, Technion City, Haifa
- Cognos Therapeutics Inc, 2026-07-02, $2M, Inglewood, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.